James Joaquin
Signal active
Co-Founder and Managing Director
Bio
James has over twenty-five years of experience building and leading technology companies from early stage company ideation to global market leadership. He helped create entirely new categories such as online photography, web-based calendaring and the Personal Digital Assistant. James is the former CEO of Ofoto, Xoom, and Xmarks.
James is the co-founder of Obvious Ventures, investing in #worldpositive startups that combine profit and purpose.
Location
San Francisco, California, United States, North America
Social
Primary Organization
Obvious Ventures
Founded
2014
Investment
161
Lead investment
44
Exits
16
Employees
11-50
Industry
Financial Services, Venture Capital, Finance, Biotechnology, Artificial Intelligence (AI), Insurance
Jobs history
1
Board Observer
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
James Joaquin is the Co-Founder and Managing Director at Obvious Ventures, based in United States, North America. With a background in Financial Services, James Joaquin has a rich history of leadership and innovation. James Joaquin studied unknown unknown @ Brown University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
James Joaquin has made 13 investments. Their Latest investment was Seed Round - Career Karma on Jul 09, 2019
Number of investment
13
Number of exits
4
Personal investment
13
| Annouced Date | Organization Name | Funding Round | Money Raised |
|---|---|---|---|
| Mar 20, 2014 | Metabiota | Seed Round - Metabiota | 2.8M |
| May 28, 2014 | Fyusion | Seed Round - Fyusion | 3.4M |
| Mar 21, 2019 | Fetcher | Seed Round - Fetcher | 5.4M |
| Jul 09, 2019 | Career Karma | Seed Round - Career Karma | 1.5M |
Metabiota
FyusionPartner investment
6
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Mar 16, 2022 | Nectar | Seed Round - Nectar | Obvious Ventures | 8.0M |
| May 24, 2022 | Parallel Learning | Series A - Parallel Learning | Obvious Ventures | 20.0M |
| Jun 01, 2022 | MycoMedica Life Sciences, PBC | Series A - MycoMedica Life Sciences, PBC | Obvious Ventures | 60.0M |
| Dec 20, 2022 | Nectar | Series A - Nectar | Obvious Ventures | 16.5M |
Obvious VenturesExits
3
Invest in industries
Recent Activity
There is no recent news or activity for this profile.